Browse our comprehensive archive of press releases by date.
Select a specific day to access all press releases published on Healthcare Times Utah.
Press releases published on September 18, 2025
Japan Ground Self-Defense Force Adopts MEDIROM MOTHER Labs’ REMONY for Advanced Health Monitoring and Heatstroke Safety
TOKYO, Sept. 18, 2025 (GLOBE NEWSWIRE) -- MEDIROM Healthcare Technologies Inc. (NASDAQ: MRM) (“MEDIROM”) today announced that its subsidiary, MEDIROM MOTHER Labs Inc. (“MOTHER Labs”), has begun providing its remote health monitoring system “REMONY,” …
DBV Technologies Announces Resignation of Board Member
Châtillon, France, September 18, 2025 DBV Technologies Announces Resignation of Board Member DBV Technologies (Euronext: DBV – ISIN: FR0010417345 – Nasdaq Market: DBVT), (the “Company” or “DBV”), a clinical-stage biopharmaceutical company, today announced …
DBV Technologies annonce la démission d’un membre de son Conseil d’administration
Châtillon, France, le 18 septembre 2025 DBV Technologies annonce la démission d’un membre de son Conseil d’administration DBV Technologies (Euronext: DBV – ISIN: FR0010417345 – Nasdaq Market: DBVT), (la “Société” ou “DBV”), une société biopharmaceutique au …
NovaBay Pharmaceuticals Issues a Reminder of Important Information Regarding the Pending Special Dividend and Upcoming 2025 Annual Meeting
EMERYVILLE, Calif., Sept. 18, 2025 (GLOBE NEWSWIRE) -- NovaBay® Pharmaceuticals, Inc. (NYSE American: NBY) (the “Company”) previously announced a one-time special cash dividend of $0.80 per share for the Company’s common stock. The special cash dividend …
Jasper Therapeutics Announces Proposed Public Offering of Common Stock, Pre-Funded Warrants and Common Warrants
REDWOOD CITY, Calif., Sept. 18, 2025 (GLOBE NEWSWIRE) -- Jasper Therapeutics, Inc. (Nasdaq: JSPR) (“Jasper”), a clinical-stage biotechnology company focused on development of briquilimab, a novel antibody therapy targeting KIT (CD117) to address mast cell …
Reviva Pharmaceuticals Holdings, Inc. Announces Proposed Public Offering
CUPERTINO, Calif., Sept. 18, 2025 (GLOBE NEWSWIRE) -- Reviva Pharmaceuticals Holdings, Inc. (NASDAQ: RVPH) (“Reviva” or the “Company”), a late-stage pharmaceutical company developing therapies that seek to address unmet medical needs in the areas of …
Tenaya Therapeutics Reports Inducement Grants under NASDAQ Listing Rule 5635(c)(4)
SOUTH SAN FRANCISCO, Calif., Sept. 18, 2025 (GLOBE NEWSWIRE) -- Tenaya Therapeutics Inc. (NASDAQ: TNYA), a clinical-stage biotechnology company with a mission to discover, develop and deliver potentially curative therapies that address the underlying …
Madrigal Pharmaceuticals Announces Grants of Inducement Awards under Nasdaq Listing Rule 5635(c)(4)
CONSHOHOCKEN, Pa., Sept. 18, 2025 (GLOBE NEWSWIRE) -- Madrigal Pharmaceuticals, Inc. (NASDAQ:MDGL), a biopharmaceutical company focused on delivering novel therapeutics for metabolic dysfunction-associated steatohepatitis (MASH), today announced that it …
Palisade Bio Announces Adjournment of Special Meeting of Stockholders Due to Lack of Quorum
Carlsbad, CA, Sept. 18, 2025 (GLOBE NEWSWIRE) -- Palisade Bio, Inc. (Nasdaq: PALI) (“Palisade”, “Palisade Bio”, or the “Company”), a clinical-stage biopharmaceutical company advancing novel therapeutics for patients living with autoimmune, inflammatory, …
Geron Corporation Reports Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)
FOSTER CITY, Calif., Sept. 18, 2025 (GLOBE NEWSWIRE) -- Geron Corporation (Nasdaq: GERN), a commercial stage biopharmaceutical company, today reported that it has granted equity awards covering an aggregate of 966,000 shares of its common stock, consisting …
iCare ABA Therapy Launches With AI-Supported Model, Sparks Industry Debate on AI’s Role in Autism Care
New York, NY, Sept. 18, 2025 (GLOBE NEWSWIRE) -- The soft launch of iCare ABA Therapy is drawing attention across healthcare, real estate, and investment circles for one reason: its deliberate investment in artificial intelligence (AI) to streamline one of …
Cytokinetics Announces Inducement Grants Under Nasdaq Listing Rule 5635(C)(4)
SOUTH SAN FRANCISCO, Calif., Sept. 18, 2025 (GLOBE NEWSWIRE) -- Cytokinetics, Incorporated (Nasdaq: CYTK) today announced that on September 15, 2025 it granted stock options to purchase an aggregate of 39,790 shares of common stock and 26,822 restricted …
Compass Health Celebrates Grand Opening of Marc Healing Center
EVERETT, Wash., Sept. 18, 2025 (GLOBE NEWSWIRE) -- After years of purposeful design, hard work and passionate community support, Compass Health celebrated the grand opening of the Marc Healing Center: the region’s newest state-of-the-art facility for …
Ceramics Industry Set for Strong Growth, Projected to Reach $62.5 Billion by 2030
Boston, Sept. 18, 2025 (GLOBE NEWSWIRE) -- According to the latest study from BCC Research, the “Ceramics Markets: A BCC Research Outlook” is expected to grow from $41.3 billion in 2025 to $62.5 billion by the end of 2030, at a compound annual growth rate …
Alameda Health System is recognized for responsible sourcing and sustainable procurement
OAKLAND, Calif., Sept. 18, 2025 (GLOBE NEWSWIRE) -- Alameda Health System (AHS) has been recognized as a top performer by Vizient® in its 2025 Responsible Sourcing Ranking. This honor is in recognition of AHS' sustainable procurement practices that drive …
Immix Biopharma Announces 50% Enrollment Milestone Surpassed in its ongoing relapsed/refractory AL Amyloidosis Clinical Trial, NEXICART-2
– On track for first FDA Biologics License Application (BLA) approved cell therapy in orphan indication relapsed/refractory AL Amyloidosis – Los Angeles, CA, Sept. 18, 2025 (GLOBE NEWSWIRE) -- Immix Biopharma, Inc. (“ImmixBio”, “Company”, “We” or “Us” or ” …
Chronic Venous Insufficiency Market to Increase at a CAGR of 9.4% During the Forecast Period (2025–2034) Due to the Launch of Emerging Therapies and Chronic Venous Insufficiency Medical Devices | DelveInsight
New York, USA, Sept. 18, 2025 (GLOBE NEWSWIRE) -- Chronic Venous Insufficiency Market to Increase at a CAGR of 9.4% During the Forecast Period (2025–2034) Due to the Launch of Emerging Therapies and Chronic Venous Insufficiency Medical Devices | …
Global Overactive Bladder Treatment Market to Exhibit Substantial Growth at a CAGR of ~4% by 2032 | DelveInsight
New York, USA, Sept. 18, 2025 (GLOBE NEWSWIRE) -- Global Overactive Bladder Treatment Market to Exhibit Substantial Growth at a CAGR of ~4% by 2032 | DelveInsight The overactive bladder treatment market is experiencing steady growth driven by the …
Toni Pashley joins Scene Health as Chief Product Officer to help solve the Medication Adherence challenge
BALTIMORE, Sept. 18, 2025 (GLOBE NEWSWIRE) -- Scene Health, a leader in MedEngagement, welcomes Toni Pashley as its new Chief Product Officer (CPO), marking a transformative moment for Scene as they accelerate their technological innovations to support …
Kuros statement on media inquiry concerning former Board member
Ad-hoc announcement pursuant to Article 53 of the SIX listing rules Kuros statement on media inquiry concerning former Board member Schlieren (Zurich), Switzerland, September 18, 2025 – Kuros Biosciences (“Kuros” or the “Company”) a leader in next …